LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹10,511 Cr | ₹9,336 Cr | ₹8,387 Cr | ₹7,660 Cr | ₹6,968 Cr |
What is the latest Total Liabilities ratio of LAURUS LABS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹10,511 Cr |
| Mar2025 | ₹9,336 Cr |
| Mar2024 | ₹8,387 Cr |
| Mar2023 | ₹7,660 Cr |
| Mar2022 | ₹6,968 Cr |
How is Total Liabilities of LAURUS LABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹10,511 Cr | 12.59 | |
| Mar2025 | ₹9,336 Cr | 11.31 | |
| Mar2024 | ₹8,387 Cr | 9.49 | |
| Mar2023 | ₹7,660 Cr | 9.94 | |
| Mar2022 | ₹6,968 Cr | - | |
Compare Total Liabilities of peers of LAURUS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LAURUS LABS | ₹99,471.9 Cr | -0.8% | 18.4% | 120.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
LAURUS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LAURUS LABS | -0.8% |
18.4% |
120.4% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses